SCHEMBL3561805

SCHEMBL3561805

N#CC(=Cc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1)C(=O)c1ccc(F)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ORAI1 Q96D31 3/20 0.47
TRPC3 Q13507 3/20 0.42
TRPC1 P48995 1/20 0.42
STIM1 Q13586 1/20 0.42
KMT2A Q03164 5/20 0.41
MEN1 O00255 4/20 0.41
EGFR P00533 4/20 0.41
ERBB2 P04626 4/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 3/20 0.41
TP53 P04637 3/20 0.41
RGS12 O14924 1/20 0.41
USP2 O75604 1/20 0.41
CYP1A2 P05177 1/20 0.41
ALPL P05186 1/20 0.41
POLB P06746 1/20 0.41
IGF1R P08069 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3563369 0.89 ALDH1A1 (0.40) ORAI1KMT2AMEN1EGFRERBB2
SCHEMBL3563366 0.89 ALDH1A1 (0.40) ORAI1KMT2AMEN1EGFRERBB2
SCHEMBL3566754 0.83 ORAI1 (0.43) ORAI1TRPC3TRPC1STIM1KMT2A
SCHEMBL3560798 0.83 ORAI1 (0.43) ORAI1TRPC3TRPC1STIM1KMT2A
SCHEMBL13404469 0.83 ORAI1 (0.43) ORAI1TRPC3TRPC1STIM1KMT2A
SCHEMBL3560131 0.80 ORAI1 (0.40) ORAI1TRPC3TRPC1STIM1KMT2A
SCHEMBL3557629 0.79 ORAI1 (0.41) ORAI1TRPC3TRPC1STIM1KMT2A
SCHEMBL3556719 0.76 ORAI1 (0.43) ORAI1TRPC3TRPC1STIM1KMT2A
SCHEMBL3567004 0.76 ORAI1 (0.41) ORAI1TRPC3TRPC1STIM1KMT2A
SCHEMBL3558103 0.75 ALDH1A1 (0.41) KMT2AMEN1EGFRERBB2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705029-B2 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2010-04-27 US disclosed
EP-1732900-A4 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP (US) 2007-12-12 EP disclosed
US-20070270478-A1 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-11-22 US disclosed
US-7202232-B2 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-04-10 US disclosed
EP-1732900-A2 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES Synta Pharmaceuticals Corporation (US) 2006-12-20 EP disclosed
US-20050272699-A1 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. 2005-12-08 US disclosed
WO-2005091752-A2 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272699-A1 Acrylonitrile derivatives for inflammation and immune-related uses IL1B, IL6, TLR4 ORAI1 3017/4885TRPC3 1960/4885TRPC1 3621/4885
US-20070270478-A1 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES IL1B, IL6, TLR4 ORAI1 3017/4885TRPC3 1960/4885TRPC1 3621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.